Oncology and Hematology News and Journal Articles
Regular use of aspirin may reduce the risk of developing cholangiocarcinoma, according to the results of a new study.
While inflammation is the body’s defense mechanism against pathogens, damaged cells, and chemical irritants, it also has a dark side.
The addition of pegylated interferon-ɑ2b to dasatinib yielded promising results in a small trial of newly diagnosed chronic myeloid leukemia patients.
The KEYNOTE-012 trial shows that pembrolizumab has activity and acceptable toxicity as single-agent therapy in advanced triple-negative breast cancer.
In this video Lindsey Radcliff, BSN, RN, of the James Cancer Hospital in Ohio, discusses steps her institution took to improve chemotherapy scheduling in an attempt to increase the number of patients scheduled and reduce patient wait times.
In this video Alexis Covert, BSN, RN, OCN, discusses a study that aimed to raise awareness among staff nurses on the assessment of cancer-related fatigue, a prevalent and distressing cancer symptoms that affects 80% to 100% cancer patients, and interventions to help treat it.
In this video Pamela K. Ginex, EdD, RN, OCN, discusses a successful partnership between a clinical librarian and the nursing staff at her institution, a collaboration that benefits staff and, ultimately, patients.
In this video Kristen Fessele, PhD, RN, AOCN, a post-doctoral research fellow at the University of Utah College of Nursing, discusses a study which examined genetic factors that affected the symptom experience of patients being treated with chemotherapy.